Bright Green (BGXX) said Friday it has signed a letter of intent to supply its marijuana extracts and plant-based psychedelics to Benuvia Operations.
Bright Green is authorized by the US government and the New Mexico Board of Pharmacy to grow, make, and sell schedule I and II plant-based drugs for research, pharmaceutical applications, and export, the company said.
Bright Green shares were 3% higher in recent trading.
Price: 0.23, Change: +0.01, Percent Change: +3.10
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments